Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rTSH PET-CT for Residual Thyroid Cancer
NCT00181168Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Mar 2001
- Primary completion
- Sep 2003
- Modality
- Biologic, rProtein (Recombinant Protein), Hormone
- Countries
- 2
01
Overview
Phase 2, single-blind trial of thyrotropin alfa in thyroid cancer (2 arms), sponsored by Johns Hopkins University. Primary endpoint: PET-CT Fusion Scanning Sensitivity at 21 Days. Started Mar 2001; status: completed.
02
Drugs
thyrotropin alfa
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT00181168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181168.